VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics
VolitionRx Limited Releases Video Featuring Interviews with its Scientific Advisory Board
VolitionRx Limited to Attend Multiple Conferences in September
VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update
Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer
VolitionRx Limited Announces Completion of Sample Collection in Endometriosis Study
VolitionRx Announces $9 Million Private Placement
VolitionRx Limited Schedules Second Quarter 2018 Earnings Conference Call and Business Update
VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today
Volition Extends Global Reach of its Clinical Trial Program
